This inventor holds 1 USPTO granted patent. Top assignees: La Jolla Pharmaceuticals Company, Vanderbilt University. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 2 
1 out of 1,221 
Years Active: 2020
Title: The Innovations of Matthew Ritter
Introduction: Matthew Ritter is an accomplished inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly through his innovative work on BMP signaling inhibitors. His research has the potential to impact various medical applications.
Latest Patents: Matthew Ritter holds a patent titled "Inhibition of BMP signaling, compounds, compositions and uses thereof." This patent describes substituted imidazo[1,2-a]pyridines that are useful as inhibitors of BMP signaling. The invention also includes pharmaceutical compositions of these compounds and outlines their medical uses.
Career Highlights: Throughout his career, Matthew Ritter has worked with notable institutions, including Vanderbilt University and La Jolla Pharmaceuticals Company. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations: Some of his notable coworkers include Corey R. Hopkins and Charles C. Hong. Their collaboration has likely contributed to the advancement of research in their respective fields.
Conclusion: Matthew Ritter's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight the importance of research in developing new medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile